Akums Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
8350.54 Cr.
|
P/BV
|
2.95
|
Book Value (Rs.)
|
180.08
|
52 Week High/Low (Rs.)
|
1176/405
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
Bookclosure
|
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 |
| | | |
PER SHARE RATIOS | | | |
| | | |
Basic EPS (Rs.) | -0.28 | 6.63 | -17.65 |
Diluted EPS (Rs.) | -0.28 | 6.63 | -17.65 |
Cash EPS (Rs.) | 8.84 | 14.74 | -21.86 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 50.36 | 50.56 | 87.39 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 50.36 | 50.56 | 87.39 |
Revenue From Operations / Share (Rs.) | 292.05 | 255.47 | 513.30 |
PBDIT / Share (Rs.) | 10.97 | 26.84 | -9.66 |
PBIT / Share (Rs.) | 2.19 | 18.96 | -22.89 |
PBT / Share (Rs.) | -3.16 | 10.52 | -27.04 |
Net Profit / Share (Rs.) | 0.05 | 6.85 | -35.10 |
NP After MI And SOA / Share (Rs.) | -0.28 | 6.63 | -35.30 |
| | | |
PROFITABILITY RATIOS | | | |
| | | |
PBDIT Margin (%) | 3.75 | 10.50 | -1.88 |
PBIT Margin (%) | 0.75 | 7.42 | -4.46 |
PBT Margin (%) | -1.08 | 4.11 | -5.26 |
Net Profit Margin (%) | 0.01 | 2.68 | -6.83 |
NP After MI And SOA Margin (%) | -0.09 | 2.59 | -6.87 |
Return on Networth / Equity (%) | -0.56 | 13.22 | -40.60 |
Return on Capital Employeed (%) | 1.36 | 13.55 | -9.11 |
Return On Assets (%) | -0.11 | 2.90 | -8.22 |
Long Term Debt / Equity (X) | 0.11 | 0.16 | 0.02 |
Total Debt / Equity (X) | 0.69 | 0.74 | 0.57 |
Asset Turnover Ratio (%) | 1.23 | 1.15 | 0.00 |
| | | |
LIQUIDITY RATIOS | | | |
| | | |
Current Ratio (X) | 1.60 | 1.52 | 1.49 |
Quick Ratio (X) | 1.08 | 0.94 | 0.91 |
Inventory Turnover Ratio (X) | 3.35 | 2.79 | 0.00 |
| | | |
COVERAGE RATIOS | | | |
| | | |
Interest Coverage Ratio (%) | 3.10 | 8.30 | -4.15 |
Interest Coverage Ratio (Post Tax) (%) | 1.53 | 4.73 | -13.30 |